These findings confirm that our K/C and K/P murine leukemia models faithfully replicate the immunophenotypic and transcriptional features of primary KAT6A-rearranged AML, providing robust systems for investigating disease mechanisms and therapeutic strategies. The gene discussed is KAT6A; the disease is acute myeloid leukemia.